Day One Biopharmaceuticals Inc (DAWN) 21.53 USD (%)

Warning: The stock Day One Biopharmaceuticals Inc has been delisted from NASDAQ market 2 months ago.

Day One Biopharmaceuticals Inc is committed to developing innovative treatments for pediatric cancers and other serious illnesses.

medical-research oncology

This stock is no longer available on the market.

Momentum is exceptionally strong and reflects a sharp shift in market perception, with the trend now being driven by a major capital event rather than by operational execution alone. The announcement of the acquisition by Servier acted as an immediate catalyst, improving medium-term visibility for the case and reducing, at least temporarily, the usual binary risk associated with listed biotechs.

Day One Biopharmaceuticals Inc

Trend Analysis of Day One Biopharmaceuticals Inc

Want to see the full analysis?